Literature DB >> 12509811

Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.

Thanasak Teaktong1, Alison Graham, Jennifer Court, Robert Perry, Evelyn Jaros, Mary Johnson, Ros Hall, Elaine Perry.   

Abstract

Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are common forms of dementia in the elderly associated with cholinergic dysfunction, including reductions in nicotinic acetylcholine receptors (nAChRs). In AD, astrocytes are implicated in the formation of senile plaques, one of the core pathological features. Using immunohistochemistry, we have investigated astrocytic expression of the two major nicotinic receptor alpha subunits in the human hippocampus and entorhinal cortex. alpha7, but not alpha4, subunit immunoreactivity was associated with astrocytes. An increase in the proportion of astrocytes expressing alpha7 immunoreactivity was observed in AD compared with age-matched controls. A similar increase was not evident in DLB. Elevated alpha7 nAChRs on astrocytes in AD may contribute to alterations in calcium homeostasis and nitric oxide production, which in turn could affect beta-amyloid-mediated inflammatory processes in AD. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509811     DOI: 10.1002/glia.10132

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  47 in total

1.  The α7 nicotinic acetylcholine receptors regulate hippocampal adult-neurogenesis in a sexually dimorphic fashion.

Authors:  Simone L Otto; Jerrel L Yakel
Journal:  Brain Struct Funct       Date:  2018-12-04       Impact factor: 3.270

Review 2.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

Review 3.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

Review 4.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

5.  Regional acetylcholinesterase activity and its correlation with behavioral performances in 15-month old transgenic mice expressing the human C99 fragment of APP.

Authors:  M Dumont; R Lalonde; J-F Ghersi-Egea; K Fukuchi; C Strazielle
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

Review 6.  Don't forget astrocytes when targeting Alzheimer's disease.

Authors:  Jessica S Sadick; Shane A Liddelow
Journal:  Br J Pharmacol       Date:  2019-02-19       Impact factor: 8.739

Review 7.  Nicotinic ACh receptors as therapeutic targets in CNS disorders.

Authors:  Kelly T Dineley; Anshul A Pandya; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2015-01-29       Impact factor: 14.819

8.  A DNA methylation fingerprint of 1628 human samples.

Authors:  Agustin F Fernandez; Yassen Assenov; Jose Ignacio Martin-Subero; Balazs Balint; Reiner Siebert; Hiroaki Taniguchi; Hiroyuki Yamamoto; Manuel Hidalgo; Aik-Choon Tan; Oliver Galm; Isidre Ferrer; Montse Sanchez-Cespedes; Alberto Villanueva; Javier Carmona; Jose V Sanchez-Mut; Maria Berdasco; Victor Moreno; Gabriel Capella; David Monk; Esteban Ballestar; Santiago Ropero; Ramon Martinez; Marta Sanchez-Carbayo; Felipe Prosper; Xabier Agirre; Mario F Fraga; Osvaldo Graña; Luis Perez-Jurado; Jaume Mora; Susana Puig; Jaime Prat; Lina Badimon; Annibale A Puca; Stephen J Meltzer; Thomas Lengauer; John Bridgewater; Christoph Bock; Manel Esteller
Journal:  Genome Res       Date:  2011-05-25       Impact factor: 9.043

Review 9.  The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer.

Authors:  Ma Reina D Improgo; Michael D Scofield; Andrew R Tapper; Paul D Gardner
Journal:  Prog Neurobiol       Date:  2010-06-04       Impact factor: 11.685

Review 10.  Glial cells as therapeutic targets for smoking cessation.

Authors:  Mohit Kumar; Adewale Adeluyi; Erin L Anderson; Jill R Turner
Journal:  Neuropharmacology       Date:  2020-05-24       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.